Private Equity Deal Spotlight | Weekly Update

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

• Accuhealth, a health care technology company specializing in remote patient monitoring, announced a merger with Signallamp Health, with additional funding from Sunstone Partners. Signallamp Health is headquartered in Scranton, Pennsylvania, and specializes in remote chronic care management to assist hospitals and health systems reduce the cost of care by maximizing patient engagement. Following the transaction, the combined company will serve physician offices and health systems across 48 states with a suite of remote patient monitoring and chronic care management services. Sunstone Partners is a San Mateo, California-based PE firm with investments in technology-enabled services and software businesses.
• Vivo Infusion, an ambulatory infusion services provider backed by InTandem Capital Partners, announced the acquisition of Infusion Associates. Infusion Associates is a provider of community-based infusion and injection care for patients suffering from compromised immune systems, cancer-related diagnoses and other medical conditions. The acquisition expands Vivo Infusion’s presence across the Midwest. Following the transaction, Vivo Infusion will manage nearly 80 ambulatory infusion centers across 15 states. InTandem Capital is a PE firm located in New York with investments throughout the health care services sector.
• SAIGroup, a private investment firm with investments in enterprise AI solutions, announced the acquisition of Get Well, with debt financing provided by Oxford Finance. Get Well combines advanced AI navigation with high-touch care experiences to improve patient activation and reduce the cost of care. Get Well has developed AI solutions that support more than 10 million patient interactions at over 1,000 health care organizations across the U.S. The acquisition furthers SAI Group’s goal of expanding AI solutions in the health care market. Oxford Finance is a specialty financial services firm with a footprint in the life sciences, health care, business services, and software and technology sectors.
• Access Infusion Care, a New Harbor Capital portfolio company and a provider of specialty and infusion services, completed the acquisition of Superior Specialty Pharmacy and Big Sky I.V. Care. Headquartered in Tampa, Florida, Superior Specialty Pharmacy is a provider of customized compounded medications. Meanwhile, Big Sky I.V. Care is a provider of home and specialty infusion services headquartered in Kalispell, Montana. The transaction marks Access Infusion Care’s first acquisition following its formation earlier this year. New Harbor Capital is a Chicago-based PE firm with investments in the health care, education and technology-enabled services industries.
• Revelation Pharma, a network of 503A and 503B compounding pharmacies backed by Osceola Capital, announced the acquisitions of Taylors Pharmacy and Key Compounding Pharmacy. Taylors Pharmacy is a national pharmacy licensed in over 41 states, while Key Compounding serves patients and providers by tailoring compound prescriptions to better meet their needs. Each acquisition is expected to expand the availability of Revelation Pharma’s products and services to patients and providers throughout the United States. Osceola Capital is a Tampa, Florida-based PE firm with investments in the business services, health care services, technology-enabled services and industrial services sectors.